Anticoagulation Flashcards
1
Q
High risk PE Initial treatment
A
Thrombolysis
UFH
2
Q
Acute PE
A
LMWH/fondaparinux) or rivaroxaban for 5 days
- Transition to VKA once INR 2-3 for 24 hrs
- Continue for 3 months if provoked (surgery)
- 3+ months if unprovoked
3
Q
PE Associated w/ hypotension and/or shock
A
- UFH
- Thrombolytic therapy
- Thrombolysis contraindicated - catheter embolectomy
4
Q
PE w/ active cancer or pregnancy
A
LMWH, for more than 3 months
- continue at least 6 wks post partum
5
Q
PE w/ CrCl < 30 mL/min
A
UFH
6
Q
PE in children
A
UFH/LMWH, with LMWH or VKA long-term
7
Q
Direct Anti-Xa
A
- Rivaroxaban (Xarelto)
- Apixaban (Eliquis)
- Edoxaban (Savaysa)
8
Q
Direct Anti-IIa
A
Dabigatran (Pradaxa)
9
Q
NOAC - no renal adjustment
A
- Apixaban (Eliquis)
10
Q
NOAC over 15mg take with food
A
Rivaroxaban (Xarelto)
